Chengdu Easton Biopharmaceuticals Co Ltd (688513)

Currency in CNY
59.12
-0.38(-0.64%)
Closed·
688513 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688513 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
58.7360.00
52 wk Range
28.8568.52
Key Statistics
Bid/Ask
59.02 / 59.12
Prev. Close
59.5
Open
60
Day's Range
58.73-60
52 wk Range
28.85-68.52
Volume
3.06M
Average Volume (3m)
4.19M
1-Year Change
77.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688513 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
43.00
Downside
-27.27%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Chengdu Easton Biopharmaceuticals Co Ltd Company Profile

Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms comprising capsules, tablets, and injections, as well as active pharmaceutical ingredients (API). It also offers API products, such as Apixaban for cardiovascular applications; Apualutamide, Bosutinib, Dacomitinib, Ibrutinib, Nilotinib HCL, Nintedanib, Relugolix, and Ruxolitinib Phosphate for oncological applications; Bricaracetam and Lacosamide for neurological and psychiatric applications; and Empagliflozin for anti-diabetic applications. The company was founded in 2009 and is based in Chengdu, China.

Employees
1522
Market
China

Compare 688513 to Peers and Sector

Metrics to compare
688513
Peers
Sector
Relationship
P/E Ratio
46.0x30.5x−0.5x
PEG Ratio
−6.88−0.160.00
Price/Book
3.7x3.2x2.6x
Price / LTM Sales
7.7x4.6x3.3x
Upside (Analyst Target)
−27.3%10.1%43.3%
Fair Value Upside
Unlock13.6%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 43.00
(-27.27% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.27%
Dividend Yield
0.73%
Industry Median 1.51%
Annualised payout
0.43
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.34 / --
Revenue / Forecast
305.64M / --
EPS Revisions
Last 90 days

688513 Income Statement

FAQ

What Stock Exchange Does Chengdu Easton Biopharmaceuticals Trade On?

Chengdu Easton Biopharmaceuticals is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Chengdu Easton Biopharmaceuticals?

The stock symbol for Chengdu Easton Biopharmaceuticals is "688513."

What Is the Chengdu Easton Biopharmaceuticals Market Cap?

As of today, Chengdu Easton Biopharmaceuticals market cap is 10.28B.

What Is Chengdu Easton Biopharmaceuticals's Earnings Per Share (TTM)?

The Chengdu Easton Biopharmaceuticals EPS (TTM) is 1.27.

When Is the Next Chengdu Easton Biopharmaceuticals Earnings Date?

Chengdu Easton Biopharmaceuticals will release its next earnings report on 16 Oct 2025.

From a Technical Analysis Perspective, Is 688513 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Chengdu Easton Biopharmaceuticals Stock Split?

Chengdu Easton Biopharmaceuticals has split 1 times.

How Many Employees Does Chengdu Easton Biopharmaceuticals Have?

Chengdu Easton Biopharmaceuticals has 1522 employees.

What is the current trading status of Chengdu Easton Biopharmaceuticals (688513)?

As of 11 Aug 2025, Chengdu Easton Biopharmaceuticals (688513) is trading at a price of 59.12, with a previous close of 59.50. The stock has fluctuated within a day range of 58.73 to 60.00, while its 52-week range spans from 28.85 to 68.52.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.